Post Profile






Blood biopsy reveals unique, targetable genetic alterations in patients with rare cancer

(University of California - San Diego) Using fragments of circulating tumor DNA in blood, University of California San Diego School of Medicine researchers were able to identify theoretically targetable genetic alterations in 66 percent of patients with cancer of unknown primary (CUP), a rare disease with seven to 12 cases per 100,000 people each year.
read more

share

Related Posts


New Bioinformatic Analysis Reveals Role of Proteins in Diabetic Kidney Disease

Health : Newswise Medical News

A new bioinformatic framework developed by researchers at University of California San Diego School of Medicine has identified key proteins significantly altered at the gene-expression level in biopsied tissue from patients with dia...

GIST Tumors Linked to NF1 Mutations, Genetic Testing Needed

Health : Newswise Medical News

Researchers at UC San Diego Moores Cancer Center, with colleagues from Memorial Sloan Kettering Cancer Center and Fox Chase Cancer Center, have determined that a specific region of the small bowel, called the duodenal-jejunal flexur...

GIST tumors linked to NF1 mutations, genetic testing needed

Diseases & Conditions / Cancer : EurekAlert: Cancer

(University of California - San Diego) Researchers at UC San Diego Moores Cancer Center, with colleagues from Memorial Sloan Kettering Cancer Center and Fox Chase Cancer Center, have determined that a specific region of the small bo...

Blood test shows promise for early-stage cancer detection

Health : Chicago Tribune: Health

A new genetic blood test might pave the way for detecting early stage cancers that often prove fatal when caught too late, a new study suggests. The test scans blood for DNA fragments released by cancerous tumors, explained lead res...

Blood Biopsy Reveals Unique, Targetable Genetic Alterations in Patients with Rare Cancer

Health : Newswise Medical News

Using fragments of circulating tumor DNA in blood, University of California San Diego School of Medicine researchers were able to identify theoretically targetable genetic alterations in 66 percent of patients with cancer of unknown...

Comments


Copyright © 2016 Regator, LLC